特发性肺纤维化治疗的研究进展

被引:5
作者
徐兴祥
朱元珏
机构
[1] 中国医学科学院中国协和医科大学北京协和医院呼吸科
关键词
特发性肺纤维化; 治疗;
D O I
暂无
中图分类号
R563.9 [其他];
学科分类号
1002 ; 100201 ;
摘要
特发性肺纤维化是一种病因不明、发病机制不清的致命性弥漫性肺间质疾病 ,由于对疾病本质认识不一致 ,治疗上较为混乱。
引用
收藏
页码:146 / 149
页数:4
相关论文
共 17 条
[1]  
Gene therapy for lung diseases:Development in the vector biology and novel concepts for gene therapy applications. Suzuki M,Matsuse T,Isigatsubo Y. Current Molecular Medicine . 2001
[2]  
Lovastatin induces fibroblast apoptosis in vitro and in vivo.A possible therapy for fibropliferative disorders. Tan A,Levrey H,Dahm C,et al. American Journal of Respiratory and Critical Care Medicine . 1999
[3]  
Pulmonary genetics, genomics , and gene therapy. Albelda SM. Chest . 2002
[4]  
Idiopathic nonspecific pulmonary fibrosis. Nagai S,Kitaichi M,Hoh H,et al. European Respiratory Journal . 1998
[5]  
Lung transplation in interstitial lung disease. Sulica R,Teirstein A,Maria LP. Current Opinion in Pulmonary Medicine . 2001
[6]  
A preliminary study of longterm treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. Zeische R,Hofbauer E,Nittmannk,et al. The New England Journal of Medicine . 1999
[7]  
Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Katzenstein AL,Mayers J. American Journal of Respiratory and Critical Care Medicine . 1998
[8]  
Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. Yaekashiwa M,Nakayama S,Ohnuma K,et al. American Journal of Respiratory and Critical Care Medicine . 1997
[9]  
Antifibrotic therapy for the treatment of pulmonary fibrosis. Joseph AL,Luis AO. The American Journal of The Medical Sciences . 2001
[10]  
Idiopathic pulmonary fibrosis:impact of oxygen and colchicines, prednisone, or no therapy on survival. Douglas WW,Ryu JH,Schroeder DR. American Journal of Respiratory and Critical Care Medicine . 2000